Propiedades psicométricas y datos normativos de la prueba ECCO_Senior: un instrumento para evaluar la comprensión gramatical en adultos mayores

El test ECCO_Senior se diseñó para evaluar la comprensión de oraciones en adultos mayores. Es una prueba corta y de fácil aplicación, que se ha empleado en distintos estudios previos. En el estudio participaron 670 personas, de 50 a 85 años de edad, que cumplían criterios de inclusión relativos al estatus cognitivo general, el estado de ánimo y porcentaje mínimo de aciertos en el test. Además de los test de cribado (MEC y GDS-15) y un cuestionario socio-demográfico, se aplicó a todos los participantes el test ECCO_Senior con el que se pueden obtener distintos índices (generales y específicos). Además de comprobar si existen diferencias entre los grupos según la edad y el nivel educativo, se evaluaron las propiedades psicométricas del test, incluyendo evidencias de validez en las que se probó la bondad de ajuste de tres modelos estructurales que sirven para identificar los índices que explican un mayor porcentaje de la varianza del constructo (comprensión de oraciones). Se ofrecen normas interpretativas del test por edad y nivel de estudios en los Apéndices. Los resultados indican que el test permite evaluar la comprensión de oraciones con una fiabilidad adecuada y es sensible a las dificultades que puede experimentar un adulto al realizar esta tarea. Los tres modelos muestran un buen ajuste y permiten concluir que las oraciones no ajustadas al orden sintáctico canónico y los distractores léxicos (si se considera el tipo de ítem) serían los mejores indicadores en términos del porcentaje de la varianza del constructo que explican.The ECCO_Senior test was designed to assess sentence comprehension in older adults. It is a short test and easy to apply, which has been used in different previous studies. The study involved 670 people, 50 to 85 years of age, who met inclusion criteria related to general cognitive status, mood and minimum percentage of performance in the test. In addition to the screening tests (MEC and GDS-15) and a socio-demographic questionnaire, the ECCO_Senior test was applied to all participants with which different indices (general and specific) can be obtained. In addition to checking if there are differences between the groups according to age and educational level, we evaluated the psychometric properties of the test, evidences of validity included, thus we tested the goodness of fit of three structural models that serve to identify the indices that explain a greater percentage of the variance of the construct (comprehension of sentences). Interpretive norms of the test are offered by age and level of studies in the Appendices. The results indicate that the test allows to evaluate sentence comprehension with adequate reliability and it is sensitive to the difficulties that an adult may experience when performing this task. The three models show a good fit and allow us to conclude that the sentences not adjusted to the canonical syntactic order and lexical foils (if the type of item is considered) would be the best indexes in terms of the percentage of construct’s variance they explain

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multicenter study using EORTC QLQ-C30 and QLQ-MY20 in RRMM patients (ClinicalTrials.gov ID NCT03188536). We assessed the non-response rate, ceiling/floor effects, internal consistency, test-retest reliability, and validity. The study included 276 patients (53.3% males, mean [SD] age of 67.4 [10.5] years). The EORTC QLQ-MY20 showed a low non-response rate, very low ceiling and floor effects, and good internal consistency. The test-retest reliability assessment revealed good temporary stability, the construct validity analysis stated four main factors similar to the ones of the original version, and the criterion validity assessment showed no differences between groups. In conclusion, the Spanish version of EORTC QLQ-MY20 is a reliable and valid tool for assessing QoL in RRMM patients.The study was sponsored and funded by Takeda Farmacéutica España.Peer reviewe

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multicenter study using EORTC QLQ-C30 and QLQ-MY20 in RRMM patients (ClinicalTrials.gov ID NCT03188536). We assessed the non-response rate, ceiling/floor effects, internal consistency, test-retest reliability, and validity. The study included 276 patients (53.3% males, mean [SD] age of 67.4 [10.5] years). The EORTC QLQ-MY20 showed a low non-response rate, very low ceiling and floor effects, and good internal consistency. The test-retest reliability assessment revealed good temporary stability, the construct validity analysis stated four main factors similar to the ones of the original version, and the criterion validity assessment showed no differences between groups. In conclusion, the Spanish version of EORTC QLQ-MY20 is a reliable and valid tool for assessing QoL in RRMM patientsEl estudio fue patrocinado y financiado por Takeda Farmacéutica Españ

Recruitment Disruption and the Role of Unaffected Populations for Potential Recovery After the Pinna nobilis Mass Mortality Event

A devastating mass mortality event (MME) very likely caused by the protozoan Haplosporidium pinnae first detected in 2016 in the Western Mediterranean Sea, is pushing the endemic bivalve Pinna nobilis to near extinction. Populations recovery, if possible, will rely on larval dispersal from unaffected sites and potential recolonization through recruitment of resistant juveniles. To assess the impact of the MME on the species’ larval recruitment, an unprecedented network of larval collector stations was implemented over several thousands of kilometers along the Western Mediterranean coasts during the 3 years after the onset of the MME. The findings of this network showed a generalized disruption in recruitment with dramatic consequences for the recovery of the species. However, there were exceptions to this pattern and recruits were recorded in a few sites where the resident population had been decimated. This hints to the importance of unaffected populations as larval exporting sources and the role of oceanographic currents in larval transport in the area, representing a beacon of hope in the current extremely worrying scenario for this emblematic species.En prens

Creación de MOOCs en la plataforma Coursebuilder para la mejora de la enseñanza online en asignaturas de Grado y Máster (Campus Salamanca y Zamora)

Memoria ID-083 Ayudas de la Universidad de Salamanca para la innovación docente, curso 2020-2021

Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

[Background] Managing the inflammatory response to SARS-Cov-2 could prevent respiratory insufficiency. Cytokine profiles could identify cases at risk of severe disease.[Methods] We designed a randomized phase II clinical trial to determine whether the combination of ruxolitinib (5 mg twice a day for 7 days followed by 10 mg BID for 7 days) plus simvastatin (40 mg once a day for 14 days), could reduce the incidence of respiratory insufficiency in COVID-19. 48 cytokines were correlated with clinical outcome.[Participants] Patients admitted due to COVID-19 infection with mild disease.[Results] Up to 92 were included. Mean age was 64 ± 17, and 28 (30%) were female. 11 (22%) patients in the control arm and 6 (12%) in the experimental arm reached an OSCI grade of 5 or higher (p = 0.29). Unsupervised analysis of cytokines detected two clusters (CL-1 and CL-2). CL-1 presented a higher risk of clinical deterioration vs CL-2 (13 [33%] vs 2 [6%] cases, p = 0.009) and death (5 [11%] vs 0 cases, p = 0.059). Supervised Machine Learning (ML) analysis led to a model that predicted patient deterioration 48h before occurrence with a 85% accuracy.[Conclusions] Ruxolitinib plus simvastatin did not impact the outcome of COVID-19. Cytokine profiling identified patients at risk of severe COVID-19 and predicted clinical deterioration.[Trial registration] https://clinicaltrials.gov/, identifier NCT04348695.The Ruxo-Sim trial has been funded by Novartis INC through an unrestricted grant. Novartis also provided ruxolitinib. Novartis did not play any role in study design, analysis or communication. Cytokine analysis has been mainly funded by the Instituto de Salud Carlos III through Fondos COVID-19 (COV20/00211). Additionally, the project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 851255). MZ acknowledges the María de Maeztu project CEX2021-001164-M funded by the MCIN/AEI/10.13039/501100011033. PB received funds from Instituto de Salud Carlos III (PI20/00002) cofinanced by Fondos Feder, and Gobierno de Navarra Proyecto LINTERNA Ref.: 0011-1411-2020-000075.With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001164-M).Peer reviewe

Anuario de estudios celianos 2014-15

La Universidad Camilo José Cela recoge en estos anuarios las investigaciones que se llevan a cabo cada año sobre la obra de quien fue su rector Honorario. Se compromete así, en colaboración con la Fundación que también lleva su nombre, con la herencia literaria y la memoria de CJC, y favorece la divulgación de las conclusiones de los estudios más importantes realizados cada año. El presente número doble (2014-2015) del Anuario de estudios celianos se articula excepcionalmente en dos apartados: ensayos y artículos y los anexos en los que se recogen los textos ganadores del VI y VII Premio de relatos Camilo José Cela para jóvenes. Una revista de vuelo universitario quiere estar también vinculada a la creación literaria que realizan las nuevas generacionesCátedra Camilo José Cela de Estudios Hispánico

Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW). Methods Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20-65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality. Results As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p = 0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.211, 95%CI 0.067-0.667, p = 0.008). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001). Conclusions Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements